Proteomicanalysis(DIA)ofpatientswithnon-muscleinvasiveandmuscleinvasivebladdercancer

Accesstoproteomicfiles(DIA)ofpatientswithtreatment-naiveMIBC(N=51),treatment-naiveNMIBC(N=17)andneoadjuvantMIBC(N=11)

31/05/2023
86 samples
DAC: EGAC00001003260
Technology: OrbitrapLumos

Access Policy1 Study Files

Metadata

Request Access

Access to proteomic files (DIA) and genomic files (nNGM assay) of MIBC and NMIBC. Access to proteomic files (DIA) of MIBC patient-derived xenografts.

The recipient of files agrees to fully consent to the Data Access Agreement (DAA) provided by the Institute of Surgical Pathology for data access of the Proteomics' colorectal and liver metastasis files, which is based on the harmonized DAA as provided by the EGA.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID	Study Title	Study Type
	Proteomic Analysis of Non-Muscle Invasive and Muscle Invasive Bladder Cancer Highlights Distinct Subgroups With Metabolic, Matrisomal, and Immune Hallmarks	Other

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID	File Type	Size	Located in